APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gene Knockout Cell Line Construction Service

Compare research editions
View pricing & licenses

Selected research

Industry Research

Gene Knockout Cell Line Construction Service Industry Research Report 2026

15 April 2026139 pages

Choose your research edition.

Industry ResearchGene Knockout Cell Line Construction Service Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Gene Knockout Cell Line Construction Service Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Gene Knockout Cell Line Construction Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gene Knockout Cell Line Construction Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Gene Knockout Cell Line Construction Service Market Analysis and Forecast 2026-2032227 pages · $4,950 USD

Market perspective

The global Gene Knockout Cell Line Construction Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Gene Knockout Cell Line Construction Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Gene Knockout Cell Line Construction Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Gene Knockout Cell Line Construction Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Gene Knockout Cell Line Construction Service include OriGene, Creative Bioarray, Horizon Discovery, Synthego, Cyagen, Cellecta, BiologicsCorp, Kyinno Bio and Porton Advanced, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Gene Knockout Cell Line Construction Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Gene Knockout Cell Line Construction Service.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Gene Knockout Cell Line Construction Service Market by Company

OriGene

Creative Bioarray

Horizon Discovery

Synthego

Cyagen

Cellecta

BiologicsCorp

Kyinno Bio

Porton Advanced

Cytosurge

AcceGen

System Biosciences

Altogen Labs

Syd Labs

Lifeasible

GenScript

Ubigene

Beyotime

Abace Biotechnology

Viewsolid Biotechnology

iGeneBio

VectorBuilder

BrainVTA

Gene Knockout Cell Line Construction Service Segment by Type

CRISPR/Cas9

TALEN

Others

Gene Knockout Cell Line Construction Service Segment by Application

Academic and Research Institutions

Pharmaceutical and Biotechnology Companies

Gene Knockout Cell Line Construction Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Knockout Cell Line Construction Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gene Knockout Cell Line Construction Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Knockout Cell Line Construction Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Gene Knockout Cell Line Construction Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Gene Knockout Cell Line Construction Service Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Gene Knockout Cell Line Construction Service Revenue Market Share by Type (2021-2026) Table 7. Global Gene Knockout Cell Line Construction Service Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Gene Knockout Cell Line Construction Service Revenue Market Share by Type (2027-2032) Table 9. Global Gene Knockout Cell Line Construction Service Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Gene Knockout Cell Line Construction Service Revenue Market Share by Application (2021-2026) Table 11. Global Gene Knockout Cell Line Construction Service Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Gene Knockout Cell Line Construction Service Revenue Market Share by Application (2027-2032) Table 13. Global Gene Knockout Cell Line Construction Service Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Gene Knockout Cell Line Construction Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Gene Knockout Cell Line Construction Service Market Share by Region (2021-2026) Table 16. Global Gene Knockout Cell Line Construction Service Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Gene Knockout Cell Line Construction Service Market Share by Region (2027-2032) Table 18. Gene Knockout Cell Line Construction Service Industry Trends Table 19. Gene Knockout Cell Line Construction Service Industry Drivers Table 20. Gene Knockout Cell Line Construction Service Industry Opportunities and Challenges Table 21. Gene Knockout Cell Line Construction Service Market Restraints Table 22. Global Top Gene Knockout Cell Line Construction Service Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Gene Knockout Cell Line Construction Service Revenue Market Share by Players (2021-2026) Table 24. Global Gene Knockout Cell Line Construction Service Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Gene Knockout Cell Line Construction Service, Headquarters and Area Served Table 26. Global Gene Knockout Cell Line Construction Service Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Gene Knockout Cell Line Construction Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Gene Knockout Cell Line Construction Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Gene Knockout Cell Line Construction Service Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Gene Knockout Cell Line Construction Service Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Gene Knockout Cell Line Construction Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Gene Knockout Cell Line Construction Service Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Gene Knockout Cell Line Construction Service Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Gene Knockout Cell Line Construction Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Gene Knockout Cell Line Construction Service Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Gene Knockout Cell Line Construction Service Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Gene Knockout Cell Line Construction Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Gene Knockout Cell Line Construction Service Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Gene Knockout Cell Line Construction Service Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Gene Knockout Cell Line Construction Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Gene Knockout Cell Line Construction Service Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Gene Knockout Cell Line Construction Service Market Size by Country (2027-2032) & (US$ Million) Table 45. OriGene Company Information Table 46. OriGene Business Overview Table 47. OriGene Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026) & (US$ Million) Table 48. OriGene Gene Knockout Cell Line Construction Service Product Portfolio Table 49. OriGene Recent Developments Table 50. Creative Bioarray Company Information Table 51. Creative Bioarray Business Overview Table 52. Creative Bioarray Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026) & (US$ Million) Table 53. Creative Bioarray Gene Knockout Cell Line Construction Service Product Portfolio Table 54. Creative Bioarray Recent Developments Table 55. Horizon Discovery Company Information Table 56. Horizon Discovery Business Overview Table 57. Horizon Discovery Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026) & (US$ Million) Table 58. Horizon Discovery Gene Knockout Cell Line Construction Service Product Portfolio Table 59. Horizon Discovery Recent Developments Table 60. Synthego Company Information Table 61. Synthego Business Overview Table 62. Synthego Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026) & (US$ Million) Table 63. Synthego Gene Knockout Cell Line Construction Service Product Portfolio Table 64. Synthego Recent Developments Table 65. Cyagen Company Information Table 66. Cyagen Business Overview Table 67. Cyagen Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026) & (US$ Million) Table 68. Cyagen Gene Knockout Cell Line Construction Service Product Portfolio Table 69. Cyagen Recent Developments Table 70. Cellecta Company Information Table 71. Cellecta Business Overview Table 72. Cellecta Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026) & (US$ Million) Table 73. Cellecta Gene Knockout Cell Line Construction Service Product Portfolio Table 74. Cellecta Recent Developments Table 75. BiologicsCorp Company Information Table 76. BiologicsCorp Business Overview Table 77. BiologicsCorp Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026) & (US$ Million) Table 78. BiologicsCorp Gene Knockout Cell Line Construction Service Product Portfolio Table 79. BiologicsCorp Recent Developments Table 80. Kyinno Bio Company Information Table 81. Kyinno Bio Business Overview Table 82. Kyinno Bio Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026) & (US$ Million) Table 83. Kyinno Bio Gene Knockout Cell Line Construction Service Product Portfolio Table 84. Kyinno Bio Recent Developments Table 85. Porton Advanced Company Information Table 86. Porton Advanced Business Overview Table 87. Porton Advanced Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026) & (US$ Million) Table 88. Porton Advanced Gene Knockout Cell Line Construction Service Product Portfolio Table 89. Porton Advanced Recent Developments Table 90. Cytosurge Company Information Table 91. Cytosurge Business Overview Table 92. Cytosurge Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026) & (US$ Million) Table 93. Cytosurge Gene Knockout Cell Line Construction Service Product Portfolio Table 94. Cytosurge Recent Developments Table 95. AcceGen Company Information Table 96. AcceGen Business Overview Table 97. AcceGen Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026) & (US$ Million) Table 98. AcceGen Gene Knockout Cell Line Construction Service Product Portfolio Table 99. AcceGen Recent Developments Table 100. System Biosciences Company Information Table 101. System Biosciences Business Overview Table 102. System Biosciences Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026) & (US$ Million) Table 103. System Biosciences Gene Knockout Cell Line Construction Service Product Portfolio Table 104. System Biosciences Recent Developments Table 105. Altogen Labs Company Information Table 106. Altogen Labs Business Overview Table 107. Altogen Labs Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026) & (US$ Million) Table 108. Altogen Labs Gene Knockout Cell Line Construction Service Product Portfolio Table 109. Altogen Labs Recent Developments Table 110. Syd Labs Company Information Table 111. Syd Labs Business Overview Table 112. Syd Labs Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026) & (US$ Million) Table 113. Syd Labs Gene Knockout Cell Line Construction Service Product Portfolio Table 114. Syd Labs Recent Developments Table 115. Lifeasible Company Information Table 116. Lifeasible Business Overview Table 117. Lifeasible Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026) & (US$ Million) Table 118. Lifeasible Gene Knockout Cell Line Construction Service Product Portfolio Table 119. Lifeasible Recent Developments Table 120. GenScript Company Information Table 121. GenScript Business Overview Table 122. GenScript Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026) & (US$ Million) Table 123. GenScript Gene Knockout Cell Line Construction Service Product Portfolio Table 124. GenScript Recent Developments Table 125. Ubigene Company Information Table 126. Ubigene Business Overview Table 127. Ubigene Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026) & (US$ Million) Table 128. Ubigene Gene Knockout Cell Line Construction Service Product Portfolio Table 129. Ubigene Recent Developments Table 130. Beyotime Company Information Table 131. Beyotime Business Overview Table 132. Beyotime Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026) & (US$ Million) Table 133. Beyotime Gene Knockout Cell Line Construction Service Product Portfolio Table 134. Beyotime Recent Developments Table 135. Abace Biotechnology Company Information Table 136. Abace Biotechnology Business Overview Table 137. Abace Biotechnology Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026) & (US$ Million) Table 138. Abace Biotechnology Gene Knockout Cell Line Construction Service Product Portfolio Table 139. Abace Biotechnology Recent Developments Table 140. Viewsolid Biotechnology Company Information Table 141. Viewsolid Biotechnology Business Overview Table 142. Viewsolid Biotechnology Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026) & (US$ Million) Table 143. Viewsolid Biotechnology Gene Knockout Cell Line Construction Service Product Portfolio Table 144. Viewsolid Biotechnology Recent Developments Table 145. iGeneBio Company Information Table 146. iGeneBio Business Overview Table 147. iGeneBio Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026) & (US$ Million) Table 148. iGeneBio Gene Knockout Cell Line Construction Service Product Portfolio Table 149. iGeneBio Recent Developments Table 150. VectorBuilder Company Information Table 151. VectorBuilder Business Overview Table 152. VectorBuilder Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026) & (US$ Million) Table 153. VectorBuilder Gene Knockout Cell Line Construction Service Product Portfolio Table 154. VectorBuilder Recent Developments Table 155. BrainVTA Company Information Table 156. BrainVTA Business Overview Table 157. BrainVTA Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026) & (US$ Million) Table 158. BrainVTA Gene Knockout Cell Line Construction Service Product Portfolio Table 159. BrainVTA Recent Developments Table 160. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Gene Knockout Cell Line Construction Service Product Image Figure 5. Global Gene Knockout Cell Line Construction Service Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Gene Knockout Cell Line Construction Service Market Share by Type: 2025 VS 2032 Figure 7. CRISPR/Cas9 Product Figure 8. TALEN Product Figure 9. Others Product Figure 10. Global Gene Knockout Cell Line Construction Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Gene Knockout Cell Line Construction Service Market Share by Application: 2025 VS 2032 Figure 12. Academic and Research Institutions Product Figure 13. Pharmaceutical and Biotechnology Companies Product Figure 14. Global Gene Knockout Cell Line Construction Service Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 15. Global Gene Knockout Cell Line Construction Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Gene Knockout Cell Line Construction Service Market Share by Region: 2025 VS 2032 Figure 17. Global Gene Knockout Cell Line Construction Service Market Share by Players in 2025 Figure 18. Global Gene Knockout Cell Line Construction Service Manufacturers Established Date Figure 19. Global Top 5 and 10 Gene Knockout Cell Line Construction Service Players Market Share by Revenue in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. North America Gene Knockout Cell Line Construction Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Gene Knockout Cell Line Construction Service Market Share by Country (2021-2032) Figure 23. United States Gene Knockout Cell Line Construction Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Canada Gene Knockout Cell Line Construction Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Mexico Gene Knockout Cell Line Construction Service Market Share by Country (2021-2032) Figure 26. Europe Gene Knockout Cell Line Construction Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Europe Gene Knockout Cell Line Construction Service Market Share by Country (2021-2032) Figure 28. Germany Gene Knockout Cell Line Construction Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. France Gene Knockout Cell Line Construction Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. U.K. Gene Knockout Cell Line Construction Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Italy Gene Knockout Cell Line Construction Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Spain Gene Knockout Cell Line Construction Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Russia Gene Knockout Cell Line Construction Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Netherlands Gene Knockout Cell Line Construction Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Nordic Countries Gene Knockout Cell Line Construction Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Gene Knockout Cell Line Construction Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Gene Knockout Cell Line Construction Service Market Share by Country (2021-2032) Figure 38. China Gene Knockout Cell Line Construction Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Japan Gene Knockout Cell Line Construction Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. South Korea Gene Knockout Cell Line Construction Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. India Gene Knockout Cell Line Construction Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. India Gene Knockout Cell Line Construction Service Market Share by Country (2021-2032) Figure 43. Australia Gene Knockout Cell Line Construction Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. China Taiwan Gene Knockout Cell Line Construction Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. Southeast Asia Gene Knockout Cell Line Construction Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. South America Gene Knockout Cell Line Construction Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. South America Gene Knockout Cell Line Construction Service Market Share by Country (2021-2032) Figure 48. Brazil Gene Knockout Cell Line Construction Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. Argentina Gene Knockout Cell Line Construction Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Chile Gene Knockout Cell Line Construction Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Colombia Gene Knockout Cell Line Construction Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Peru Gene Knockout Cell Line Construction Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. OriGene Revenue Growth Rate in Gene Knockout Cell Line Construction Service Business (2021-2026) Figure 54. Creative Bioarray Revenue Growth Rate in Gene Knockout Cell Line Construction Service Business (2021-2026) Figure 55. Horizon Discovery Revenue Growth Rate in Gene Knockout Cell Line Construction Service Business (2021-2026) Figure 56. Synthego Revenue Growth Rate in Gene Knockout Cell Line Construction Service Business (2021-2026) Figure 57. Cyagen Revenue Growth Rate in Gene Knockout Cell Line Construction Service Business (2021-2026) Figure 58. Cellecta Revenue Growth Rate in Gene Knockout Cell Line Construction Service Business (2021-2026) Figure 59. BiologicsCorp Revenue Growth Rate in Gene Knockout Cell Line Construction Service Business (2021-2026) Figure 60. Kyinno Bio Revenue Growth Rate in Gene Knockout Cell Line Construction Service Business (2021-2026) Figure 61. Porton Advanced Revenue Growth Rate in Gene Knockout Cell Line Construction Service Business (2021-2026) Figure 62. Cytosurge Revenue Growth Rate in Gene Knockout Cell Line Construction Service Business (2021-2026) Figure 63. AcceGen Revenue Growth Rate in Gene Knockout Cell Line Construction Service Business (2021-2026) Figure 64. System Biosciences Revenue Growth Rate in Gene Knockout Cell Line Construction Service Business (2021-2026) Figure 65. Altogen Labs Revenue Growth Rate in Gene Knockout Cell Line Construction Service Business (2021-2026) Figure 66. Syd Labs Revenue Growth Rate in Gene Knockout Cell Line Construction Service Business (2021-2026) Figure 67. Lifeasible Revenue Growth Rate in Gene Knockout Cell Line Construction Service Business (2021-2026) Figure 68. GenScript Revenue Growth Rate in Gene Knockout Cell Line Construction Service Business (2021-2026) Figure 69. Ubigene Revenue Growth Rate in Gene Knockout Cell Line Construction Service Business (2021-2026) Figure 70. Beyotime Revenue Growth Rate in Gene Knockout Cell Line Construction Service Business (2021-2026) Figure 71. Abace Biotechnology Revenue Growth Rate in Gene Knockout Cell Line Construction Service Business (2021-2026) Figure 72. Viewsolid Biotechnology Revenue Growth Rate in Gene Knockout Cell Line Construction Service Business (2021-2026) Figure 73. iGeneBio Revenue Growth Rate in Gene Knockout Cell Line Construction Service Business (2021-2026) Figure 74. VectorBuilder Revenue Growth Rate in Gene Knockout Cell Line Construction Service Business (2021-2026) Figure 75. BrainVTA Revenue Growth Rate in Gene Knockout Cell Line Construction Service Business (2021-2026)

Scope & coverage.

Types
  • CRISPR/Cas9
  • TALEN
  • Others
Applications
  • Academic and Research Institutions
  • Pharmaceutical and Biotechnology Companies
Companies covered
  • OriGene
  • Creative Bioarray
  • Horizon Discovery
  • Synthego
  • Cyagen
  • Cellecta
  • BiologicsCorp
  • Kyinno Bio
  • Porton Advanced
  • Cytosurge
  • AcceGen
  • System Biosciences
  • Altogen Labs
  • Syd Labs
  • Lifeasible
  • GenScript
  • Ubigene
  • Beyotime
  • Abace Biotechnology
  • Viewsolid Biotechnology
  • iGeneBio
  • VectorBuilder
  • BrainVTA

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Gene Knockout Cell Line Construction Service by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 CRISPR/Cas9
  5. 2.2.3 TALEN
  6. 2.2.4 Others
  7. 2.3 Gene Knockout Cell Line Construction Service by Application
  8. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  9. 2.3.2 Academic and Research Institutions
  10. 2.3.3 Pharmaceutical and Biotechnology Companies
  11. 2.4 Assumptions and Limitations
3 Gene Knockout Cell Line Construction Service Breakdown Data by Type
  1. 3.1 Global Gene Knockout Cell Line Construction Service Historic Market Size by Type (2021-2026)
  2. 3.2 Global Gene Knockout Cell Line Construction Service Forecasted Market Size by Type (2027-2032)
4 Gene Knockout Cell Line Construction Service Breakdown Data by Application
  1. 4.1 Global Gene Knockout Cell Line Construction Service Historic Market Size by Application (2021-2026)
  2. 4.2 Global Gene Knockout Cell Line Construction Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Gene Knockout Cell Line Construction Service Market Perspective (2021-2032)
  2. 5.2 Global Gene Knockout Cell Line Construction Service Growth Trends by Region
  3. 5.2.1 Global Gene Knockout Cell Line Construction Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Gene Knockout Cell Line Construction Service Historic Market Size by Region (2021-2026)
  5. 5.2.3 Gene Knockout Cell Line Construction Service Forecasted Market Size by Region (2027-2032)
  6. 5.3 Gene Knockout Cell Line Construction Service Market Dynamics
  7. 5.3.1 Gene Knockout Cell Line Construction Service Industry Trends
  8. 5.3.2 Gene Knockout Cell Line Construction Service Market Drivers
  9. 5.3.3 Gene Knockout Cell Line Construction Service Market Challenges
  10. 5.3.4 Gene Knockout Cell Line Construction Service Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Gene Knockout Cell Line Construction Service Players by Revenue
  2. 6.1.1 Global Top Gene Knockout Cell Line Construction Service Players by Revenue (2021-2026)
  3. 6.1.2 Global Gene Knockout Cell Line Construction Service Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Gene Knockout Cell Line Construction Service Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Gene Knockout Cell Line Construction Service Head Office and Area Served
  6. 6.4 Global Gene Knockout Cell Line Construction Service Players, Product Type & Application
  7. 6.5 Global Gene Knockout Cell Line Construction Service Manufacturers Established Date
  8. 6.6 Global Gene Knockout Cell Line Construction Service Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Gene Knockout Cell Line Construction Service Market Size (2021-2032)
  2. 7.2 North America Gene Knockout Cell Line Construction Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Gene Knockout Cell Line Construction Service Market Size by Country (2021-2026)
  4. 7.4 North America Gene Knockout Cell Line Construction Service Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Gene Knockout Cell Line Construction Service Market Size (2021-2032)
  2. 8.2 Europe Gene Knockout Cell Line Construction Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Gene Knockout Cell Line Construction Service Market Size by Country (2021-2026)
  4. 8.4 Europe Gene Knockout Cell Line Construction Service Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Gene Knockout Cell Line Construction Service Market Size (2021-2032)
  2. 9.2 Asia-Pacific Gene Knockout Cell Line Construction Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Gene Knockout Cell Line Construction Service Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Gene Knockout Cell Line Construction Service Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Gene Knockout Cell Line Construction Service Market Size (2021-2032)
  2. 10.2 South America Gene Knockout Cell Line Construction Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Gene Knockout Cell Line Construction Service Market Size by Country (2021-2026)
  4. 10.4 South America Gene Knockout Cell Line Construction Service Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Gene Knockout Cell Line Construction Service Market Size (2021-2032)
  2. 11.2 Middle East & Africa Gene Knockout Cell Line Construction Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Gene Knockout Cell Line Construction Service Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Gene Knockout Cell Line Construction Service Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 OriGene
  2. 12.1.1 OriGene Company Information
  3. 12.1.2 OriGene Business Overview
  4. 12.1.3 OriGene Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026)
  5. 12.1.4 OriGene Gene Knockout Cell Line Construction Service Product Portfolio
  6. 12.1.5 OriGene Recent Developments
  7. 12.2 Creative Bioarray
  8. 12.2.1 Creative Bioarray Company Information
  9. 12.2.2 Creative Bioarray Business Overview
  10. 12.2.3 Creative Bioarray Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026)
  11. 12.2.4 Creative Bioarray Gene Knockout Cell Line Construction Service Product Portfolio
  12. 12.2.5 Creative Bioarray Recent Developments
  13. 12.3 Horizon Discovery
  14. 12.3.1 Horizon Discovery Company Information
  15. 12.3.2 Horizon Discovery Business Overview
  16. 12.3.3 Horizon Discovery Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026)
  17. 12.3.4 Horizon Discovery Gene Knockout Cell Line Construction Service Product Portfolio
  18. 12.3.5 Horizon Discovery Recent Developments
  19. 12.4 Synthego
  20. 12.4.1 Synthego Company Information
  21. 12.4.2 Synthego Business Overview
  22. 12.4.3 Synthego Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026)
  23. 12.4.4 Synthego Gene Knockout Cell Line Construction Service Product Portfolio
  24. 12.4.5 Synthego Recent Developments
  25. 12.5 Cyagen
  26. 12.5.1 Cyagen Company Information
  27. 12.5.2 Cyagen Business Overview
  28. 12.5.3 Cyagen Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026)
  29. 12.5.4 Cyagen Gene Knockout Cell Line Construction Service Product Portfolio
  30. 12.5.5 Cyagen Recent Developments
  31. 12.6 Cellecta
  32. 12.6.1 Cellecta Company Information
  33. 12.6.2 Cellecta Business Overview
  34. 12.6.3 Cellecta Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026)
  35. 12.6.4 Cellecta Gene Knockout Cell Line Construction Service Product Portfolio
  36. 12.6.5 Cellecta Recent Developments
  37. 12.7 BiologicsCorp
  38. 12.7.1 BiologicsCorp Company Information
  39. 12.7.2 BiologicsCorp Business Overview
  40. 12.7.3 BiologicsCorp Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026)
  41. 12.7.4 BiologicsCorp Gene Knockout Cell Line Construction Service Product Portfolio
  42. 12.7.5 BiologicsCorp Recent Developments
  43. 12.8 Kyinno Bio
  44. 12.8.1 Kyinno Bio Company Information
  45. 12.8.2 Kyinno Bio Business Overview
  46. 12.8.3 Kyinno Bio Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026)
  47. 12.8.4 Kyinno Bio Gene Knockout Cell Line Construction Service Product Portfolio
  48. 12.8.5 Kyinno Bio Recent Developments
  49. 12.9 Porton Advanced
  50. 12.9.1 Porton Advanced Company Information
  51. 12.9.2 Porton Advanced Business Overview
  52. 12.9.3 Porton Advanced Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026)
  53. 12.9.4 Porton Advanced Gene Knockout Cell Line Construction Service Product Portfolio
  54. 12.9.5 Porton Advanced Recent Developments
  55. 12.10 Cytosurge
  56. 12.10.1 Cytosurge Company Information
  57. 12.10.2 Cytosurge Business Overview
  58. 12.10.3 Cytosurge Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026)
  59. 12.10.4 Cytosurge Gene Knockout Cell Line Construction Service Product Portfolio
  60. 12.10.5 Cytosurge Recent Developments
  61. 12.11 AcceGen
  62. 12.11.1 AcceGen Company Information
  63. 12.11.2 AcceGen Business Overview
  64. 12.11.3 AcceGen Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026)
  65. 12.11.4 AcceGen Gene Knockout Cell Line Construction Service Product Portfolio
  66. 12.11.5 AcceGen Recent Developments
  67. 12.12 System Biosciences
  68. 12.12.1 System Biosciences Company Information
  69. 12.12.2 System Biosciences Business Overview
  70. 12.12.3 System Biosciences Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026)
  71. 12.12.4 System Biosciences Gene Knockout Cell Line Construction Service Product Portfolio
  72. 12.12.5 System Biosciences Recent Developments
  73. 12.13 Altogen Labs
  74. 12.13.1 Altogen Labs Company Information
  75. 12.13.2 Altogen Labs Business Overview
  76. 12.13.3 Altogen Labs Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026)
  77. 12.13.4 Altogen Labs Gene Knockout Cell Line Construction Service Product Portfolio
  78. 12.13.5 Altogen Labs Recent Developments
  79. 12.14 Syd Labs
  80. 12.14.1 Syd Labs Company Information
  81. 12.14.2 Syd Labs Business Overview
  82. 12.14.3 Syd Labs Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026)
  83. 12.14.4 Syd Labs Gene Knockout Cell Line Construction Service Product Portfolio
  84. 12.14.5 Syd Labs Recent Developments
  85. 12.15 Lifeasible
  86. 12.15.1 Lifeasible Company Information
  87. 12.15.2 Lifeasible Business Overview
  88. 12.15.3 Lifeasible Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026)
  89. 12.15.4 Lifeasible Gene Knockout Cell Line Construction Service Product Portfolio
  90. 12.15.5 Lifeasible Recent Developments
  91. 12.16 GenScript
  92. 12.16.1 GenScript Company Information
  93. 12.16.2 GenScript Business Overview
  94. 12.16.3 GenScript Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026)
  95. 12.16.4 GenScript Gene Knockout Cell Line Construction Service Product Portfolio
  96. 12.16.5 GenScript Recent Developments
  97. 12.17 Ubigene
  98. 12.17.1 Ubigene Company Information
  99. 12.17.2 Ubigene Business Overview
  100. 12.17.3 Ubigene Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026)
  101. 12.17.4 Ubigene Gene Knockout Cell Line Construction Service Product Portfolio
  102. 12.17.5 Ubigene Recent Developments
  103. 12.18 Beyotime
  104. 12.18.1 Beyotime Company Information
  105. 12.18.2 Beyotime Business Overview
  106. 12.18.3 Beyotime Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026)
  107. 12.18.4 Beyotime Gene Knockout Cell Line Construction Service Product Portfolio
  108. 12.18.5 Beyotime Recent Developments
  109. 12.19 Abace Biotechnology
  110. 12.19.1 Abace Biotechnology Company Information
  111. 12.19.2 Abace Biotechnology Business Overview
  112. 12.19.3 Abace Biotechnology Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026)
  113. 12.19.4 Abace Biotechnology Gene Knockout Cell Line Construction Service Product Portfolio
  114. 12.19.5 Abace Biotechnology Recent Developments
  115. 12.20 Viewsolid Biotechnology
  116. 12.20.1 Viewsolid Biotechnology Company Information
  117. 12.20.2 Viewsolid Biotechnology Business Overview
  118. 12.20.3 Viewsolid Biotechnology Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026)
  119. 12.20.4 Viewsolid Biotechnology Gene Knockout Cell Line Construction Service Product Portfolio
  120. 12.20.5 Viewsolid Biotechnology Recent Developments
  121. 12.21 iGeneBio
  122. 12.21.1 iGeneBio Company Information
  123. 12.21.2 iGeneBio Business Overview
  124. 12.21.3 iGeneBio Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026)
  125. 12.21.4 iGeneBio Gene Knockout Cell Line Construction Service Product Portfolio
  126. 12.21.5 iGeneBio Recent Developments
  127. 12.22 VectorBuilder
  128. 12.22.1 VectorBuilder Company Information
  129. 12.22.2 VectorBuilder Business Overview
  130. 12.22.3 VectorBuilder Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026)
  131. 12.22.4 VectorBuilder Gene Knockout Cell Line Construction Service Product Portfolio
  132. 12.22.5 VectorBuilder Recent Developments
  133. 12.23 BrainVTA
  134. 12.23.1 BrainVTA Company Information
  135. 12.23.2 BrainVTA Business Overview
  136. 12.23.3 BrainVTA Revenue in Gene Knockout Cell Line Construction Service Business (2021-2026)
  137. 12.23.4 BrainVTA Gene Knockout Cell Line Construction Service Product Portfolio
  138. 12.23.5 BrainVTA Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst